New Delhi: Many weight loss medicines are available in the market now. Nowadays people hope for quick results for weight loss. For which now an American company Eli Lilly has developed an experimental weight loss shot. Retretutide is an injection to help with weight loss. It tinkers with the body’s hormones that regulate appetite. The results are incredible. This retretutide shot reduces weight loss in obese patients by 24 percent of their body weight after 48 weeks. These results are far greater than any other anti-obesity drug.
- 24 percent weight loss in 48 weeks
- There are no side effects after taking the injection
Currently, there are numerous players in the weight loss game such as Novo Nordisk, Pfizer, AstraZeneca and Amgen. They all promise one thing, which is weight loss.
Weight can be easily reduced by a simple injection
Over the past decade, such weight loss drug treatments have shown little benefit and many side effects. But now Lilly’s new drug has raised the bar by showing that weight loss can be easily achieved with a simple injection. Lilly’s shares rose sharply after the news. This shows that Lilly can dominate the weight loss market. Notably, drugs that help in weight loss are expensive and unaffordable for many people. However, the demand continues to increase as people see the results of these drugs. Apart from the price, most of these drugs come with the same set of side effects like nausea, diarrhea, vomiting, constipation. As the dose increases, these problems worsen. Some even have increased heart rate.
Today, 38 percent of the world’s population is obese. However, this may increase to 51 percent in 12 years.